Thailand Breaks Patents For Plavix, HIV/AIDS Drug

Law360, New York (January 29, 2007, 12:00 AM EST) -- The Thai government said Monday that is has approved the compulsory licensing of two drugs, one for treating heart disease and one for HIV/AIDS, paving the way for the sale of generic versions of the drugs in that country and effectively breaking their patents.

Thailand’s public health minister, Mongkol Na Songkhla, told reporters that laws were signed Friday that allow for the production of generic versions of Plavix, a blood pressure medication made by Bristol-Myers Squibb Co. and Sanofi-Aventis, and Kaletra, Abbott Laboratories’ “second-line” treatment for...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.